Cofoe Medical Technology Stock Beta
| 301087 Stock | 37.05 0.33 0.88% |
Cofoe Medical Technology fundamentals help investors to digest information that contributes to Cofoe Medical's financial success or failures. It also enables traders to predict the movement of Cofoe Stock. The fundamental analysis module provides a way to measure Cofoe Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cofoe Medical stock.
Cofoe | Beta |
Cofoe Medical Technology Company Beta Analysis
Cofoe Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Cofoe Medical Beta | 1.02 |
Most of Cofoe Medical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cofoe Medical Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Cofoe Medical Technology has a Beta of 1.021. This is 18.72% higher than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 1.04) industry. The beta for all China stocks is notably lower than that of the firm.
Cofoe Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cofoe Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cofoe Medical could also be used in its relative valuation, which is a method of valuing Cofoe Medical by comparing valuation metrics of similar companies.Cofoe Medical is currently under evaluation in beta category among its peers.
Cofoe Medical returns are very sensitive to returns on the market. As the market goes up or down, Cofoe Medical is expected to follow.
Cofoe Fundamentals
| Return On Equity | 0.0544 | ||||
| Return On Asset | 0.022 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 6.08 B | ||||
| Shares Outstanding | 209.09 M | ||||
| Shares Owned By Insiders | 61.08 % | ||||
| Shares Owned By Institutions | 14.60 % | ||||
| Price To Book | 1.65 X | ||||
| Price To Sales | 2.60 X | ||||
| Revenue | 2.85 B | ||||
| Gross Profit | 979.57 M | ||||
| EBITDA | 336.62 M | ||||
| Net Income | 254.28 M | ||||
| Total Debt | 402.43 M | ||||
| Book Value Per Share | 23.32 X | ||||
| Cash Flow From Operations | 393.82 M | ||||
| Earnings Per Share | 1.31 X | ||||
| Target Price | 49.0 | ||||
| Number Of Employees | 5.13 K | ||||
| Beta | 1.02 | ||||
| Market Capitalization | 7.75 B | ||||
| Total Asset | 6.24 B | ||||
| Retained Earnings | 828.64 M | ||||
| Working Capital | 2.74 B | ||||
| Annual Yield | 0.05 % | ||||
| Net Asset | 6.24 B | ||||
| Last Dividend Paid | 1.8 |
About Cofoe Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cofoe Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cofoe Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cofoe Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Cofoe Stock
Cofoe Medical financial ratios help investors to determine whether Cofoe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cofoe with respect to the benefits of owning Cofoe Medical security.